In Brazil, medicines lose patent protection 20 years after the original filing date.
The filing date was in 2006, so the patent expires in 2026.
But note that the patent was only granted in 2019, it took 13 years. They went to court last year, but the justice (as far as I know) has continued to follow the precedent that the original filing date applies.
So they went to the federal government to try to change the law, but the government has refused so far.
The INPI (Brazilian Patent Office) used to take a VERY long time to register/grant patents. It's faster now (about 4 years on average), but it's still slow.
But I'm seeing here that in the US it was 2017. So not that different from 2019 anyway.
PS: Brazil also have several local labs focused on generics, and besides this, there's also state-owned lab, Fiocruz, who makes vaccines and medicines as well, several of them, to distribute though SUS.
In Brazil by the constitution, everyone has the right of health, so if the public health care (SUS) don't distribute, you can sue the governament and get the medicine. So there's a big incentive for the governament to make patents expire as soon as possible to have generics and include on SUS.
e.g Fiocruz manufacture PrEP, and started now PrEP injection (Cabotegravir).
But note that the patent was only granted in 2019, it took 13 years. They went to court last year, but the justice (as far as I know) has continued to follow the precedent that the original filing date applies.
So they went to the federal government to try to change the law, but the government has refused so far.
The INPI (Brazilian Patent Office) used to take a VERY long time to register/grant patents. It's faster now (about 4 years on average), but it's still slow.
But I'm seeing here that in the US it was 2017. So not that different from 2019 anyway.
PS: Brazil also have several local labs focused on generics, and besides this, there's also state-owned lab, Fiocruz, who makes vaccines and medicines as well, several of them, to distribute though SUS.
In Brazil by the constitution, everyone has the right of health, so if the public health care (SUS) don't distribute, you can sue the governament and get the medicine. So there's a big incentive for the governament to make patents expire as soon as possible to have generics and include on SUS.
e.g Fiocruz manufacture PrEP, and started now PrEP injection (Cabotegravir).